ライフサイエンスコーパス: mesenteric ischemia

1 fter heart operation (P = 0.03 compared with mesenteric ischemia).

2 atients with intestinal failure secondary to mesenteric ischemia.

3 ies that report on current outcome for acute mesenteric ischemia.

4 lood flow in this model of endotoxin-induced mesenteric ischemia.

5 is a promising test for diagnosis of chronic mesenteric ischemia.

6 se patients may predict the onset of chronic mesenteric ischemia.

7 e asymptomatic and 3 had symptoms of chronic mesenteric ischemia.

8 atient eventually died because of subsequent mesenteric ischemia.

9 ment of operative risk (standard deviations: mesenteric ischemia 20.2% vs 23.2%, P = 0.01; gastrointe

10 compared with surgeons in the control group [mesenteric ischemia: 43.7% vs 64.6%, P < 0.001 (RCV = 25

11 Acute mesenteric ischemia (AMI) remains a complex and difficul

12 osses were sustained by the hospital for the mesenteric ischemia and infected aortic graft groups amo

13 tural and functional changes associated with mesenteric ischemia and reperfusion in rats.

14 al damage to the intestinal mucosa caused by mesenteric ischemia and reperfusion in rats.

15 xygen species-mediated tissue injury, namely mesenteric ischemia and reperfusion in rats.

16 IL-1alpha treatment attenuates mesenteric ischemia and reperfusion injury induced by th

17 laparotomy confirmed extensive nonocclusive mesenteric ischemia, and the patient rapidly died of mul

18 and/or preemptively diagnosis postcardiotomy mesenteric ischemia are necessary to decrease its associ

19 at 5 g once daily in a patient with chronic mesenteric ischemia (CMI) for chronic loose, frequent, a

20 consecutive series of patients with chronic mesenteric ischemia (CMI) who were treated with percutan

21 clinician to identify patients in whom acute mesenteric ischemia develops.

22 in vivo, can be used to diagnose and monitor mesenteric ischemia due to hemorrhagic shock in a canine

23 nts undergoing revascularization for chronic mesenteric ischemia, elective thoracoabdominal aortic an

24 nesthesia, rats were subjected to 60 mins of mesenteric ischemia followed by 60 mins of reperfusion.

25 od flow by 60% in this model of nonocclusive mesenteric ischemia (from 168 +/- 41 to 269 +/- 76 mL/mi

26 767) with four detailed clinical vignettes (mesenteric ischemia, gastrointestinal bleed, bowel obstr

27 Mesenteric ischemia, infection, and inflammatory bowel d

28 Acute mesenteric ischemia is associated with high morbidity an

29 y be an effective treatment for nonocclusive mesenteric ischemia, it has also been advocated to incre

30 ficits, altered mental status, myocardial or mesenteric ischemia, kidney failure, hypotension, cardia

31 ssess intestinal viability in a laparoscopic mesenteric ischemia model.

32 cm (OR, 6.04; 95% CI, 2.87-12.73; P<0.001), mesenteric ischemia (OR, 9.03; 95% CI, 3.49-23.38; P<0.0

33 on, arterial thromboembolism, renal failure, mesenteric ischemia, or hepatic insufficiency occurred.

34 ue damage, we also studied its expression in mesenteric ischemia-reperfusion (I/R) injury.

35 Mesenteric ischemia-reperfusion injury was induced in ma

36 sm repair, with its requisite intraoperative mesenteric ischemia-reperfusion, often results in the de

37 2-deficient (Cr2(-/-)) mice are resistant to mesenteric ischemia/reperfusion (I/R) injury because the

38 tural Abs have been implicated in initiating mesenteric ischemia/reperfusion (I/R)-induced tissue inj

39 lthough not as common, the mortality rate of mesenteric ischemia/reperfusion (IR) remains >70%.

40 nhibited repair of damaged mucosa induced by mesenteric ischemia/reperfusion in the small intestine a

41 trates that the mechanism of U74389F against mesenteric ischemia/reperfusion includes a delay and red

42 mplement activation prevents and/or reverses mesenteric ischemia/reperfusion-induced injury in mice.

43 f the gut barrier function after exposure to mesenteric ischemia/reperfusion.

44 e to the intestinal mucosa in a rat model of mesenteric ischemia/reperfusion.

45 se and six patients with symptomatic chronic mesenteric ischemia, the same measurements were obtained

46 small bowel enteroscopy; early diagnosis of mesenteric ischemia; the use of polymerase chain reactio

47 Nonocclusive acute mesenteric ischemia was induced by pericardial tamponade

48 The diagnosis of acute mesenteric ischemia was proposed based on evidence of po

49 he most frequent serious GI complication was mesenteric ischemia, which developed in 31 (67%) patient

50 hic GI complication after cardiac surgery is mesenteric ischemia, which is frequently fatal.

51 Of the 9 patients with mesenteric ischemia who were not explored, 7 (78%) died